News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Dr. Ovidio Calvo is winning the Uromigos darts
Photo from Uromigos/X
Jun 16, 2024, 18:26

Dr. Ovidio Calvo is winning the Uromigos darts

Uromigos shared a post on X:

“There are not too many ways of getting tickets to Uromigos Live 2024 in September in Nashville, but winning the Uromigos darts competition at the annual party is one.

Dr. Ovidio Calvo threw magic darts (only 1 actually) and cleaned up. Welcome to Nashville.”

Source: Uromigos/X

cancer OncoDaily Oncology Ovidio Calvo Uromigos Uromigos Live 2024
Special Coverage
Blog
Mar 29, 2025, 23:14
Join us live for the Open Plenary Session: Common Sense Oncology
Insight
Mar 29, 2025, 23:04
Naveen Pemmaraju: Polycythemia vera: past, present and future
Insight
Mar 29, 2025, 21:34
Elvina Almuradova: Pembrolizumab plus CRT as the New Standard in Locally Advanced Cervical Cancer
Blog
Mar 29, 2025, 21:16
Shivani Modi: Honored to present 3 posters at ASCO and 5 published abstracts
Blog
Mar 29, 2025, 20:53
We’re Back for the Jimmy Fund Walk 2025: Florez Lab
Blog
Mar 29, 2025, 20:49
We hosted an engaging panel at eMerge Americas - Sylvester Comprehensive Cancer Center
Blog
Mar 29, 2025, 20:40
In 2024, the AACR Grants Program distributed more than $8 million to support 50 meritorious research projects
Blog
Mar 29, 2025, 20:35
Sakhr Alshwayyat: Our abstracts have been accepted for presentation and publication at ASCO 2025
Blog
Mar 29, 2025, 20:30
Hil Moss: Fun to be in DC today for the National Coalition for Cancer Survivorship Cancer Policy Roundtable
Blog
Mar 29, 2025, 20:24
Amy C. Moore: Learn and share about the growing importance of these little circles of DNA in tumor development
Blog
Mar 29, 2025, 20:20
Benjamin L. Ebert: We know the importance and impact of having access to the best cancer treatment
Blog
Mar 29, 2025, 20:20
Patrick Hwu: Inhibiting MDK could be a valuable strategy to improve immunotherapy outcomes in melanoma